Global Non-invasive Parenteral Screening Market Research Report 2023

Report ID: 2009653 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Instruments
        1.2.3 Consumables
    1.3 Market by Application
        1.3.1 Global Non-invasive Parenteral Screening Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diagnostic Laboratories
        1.3.3 Hospitals
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Non-invasive Parenteral Screening Market Perspective (2017-2028)
    2.2 Non-invasive Parenteral Screening Growth Trends by Region
        2.2.1 Non-invasive Parenteral Screening Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Non-invasive Parenteral Screening Historic Market Size by Region (2017-2022)
        2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Region (2023-2028)
    2.3 Non-invasive Parenteral Screening Market Dynamics
        2.3.1 Non-invasive Parenteral Screening Industry Trends
        2.3.2 Non-invasive Parenteral Screening Market Drivers
        2.3.3 Non-invasive Parenteral Screening Market Challenges
        2.3.4 Non-invasive Parenteral Screening Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Non-invasive Parenteral Screening Players by Revenue
        3.1.1 Global Top Non-invasive Parenteral Screening Players by Revenue (2017-2022)
        3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2017-2022)
    3.2 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
    3.4 Global Non-invasive Parenteral Screening Market Concentration Ratio
        3.4.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2021
    3.5 Non-invasive Parenteral Screening Key Players Head office and Area Served
    3.6 Key Players Non-invasive Parenteral Screening Product Solution and Service
    3.7 Date of Enter into Non-invasive Parenteral Screening Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Parenteral Screening Breakdown Data by Type
    4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2017-2022)
    4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2023-2028)
5 Non-invasive Parenteral Screening Breakdown Data by Application
    5.1 Global Non-invasive Parenteral Screening Historic Market Size by Application (2017-2022)
    5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Non-invasive Parenteral Screening Market Size (2017-2028)
    6.2 North America Non-invasive Parenteral Screening Market Size by Country (2017-2022)
    6.3 North America Non-invasive Parenteral Screening Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Non-invasive Parenteral Screening Market Size (2017-2028)
    7.2 Europe Non-invasive Parenteral Screening Market Size by Country (2017-2022)
    7.3 Europe Non-invasive Parenteral Screening Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Non-invasive Parenteral Screening Market Size (2017-2028)
    8.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Country (2017-2022)
    8.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Non-invasive Parenteral Screening Market Size (2017-2028)
    9.2 Latin America Non-invasive Parenteral Screening Market Size by Country (2017-2022)
    9.3 Latin America Non-invasive Parenteral Screening Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Non-invasive Parenteral Screening Market Size (2017-2028)
    10.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2017-2022)
    10.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Detail
        11.1.2 GE Healthcare Business Overview
        11.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
        11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.1.5 GE Healthcare Recent Development
    11.2 Philips
        11.2.1 Philips Company Detail
        11.2.2 Philips Business Overview
        11.2.3 Philips Non-invasive Parenteral Screening Introduction
        11.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.2.5 Philips Recent Development
    11.3 Illumina
        11.3.1 Illumina Company Detail
        11.3.2 Illumina Business Overview
        11.3.3 Illumina Non-invasive Parenteral Screening Introduction
        11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.3.5 Illumina Recent Development
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Company Detail
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
        11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.4.5 Thermo Fisher Scientific Recent Development
    11.5 Roche
        11.5.1 Roche Company Detail
        11.5.2 Roche Business Overview
        11.5.3 Roche Non-invasive Parenteral Screening Introduction
        11.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.5.5 Roche Recent Development
    11.6 PacBio
        11.6.1 PacBio Company Detail
        11.6.2 PacBio Business Overview
        11.6.3 PacBio Non-invasive Parenteral Screening Introduction
        11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.6.5 PacBio Recent Development
    11.7 Perkinelmer
        11.7.1 Perkinelmer Company Detail
        11.7.2 Perkinelmer Business Overview
        11.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
        11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.7.5 Perkinelmer Recent Development
    11.8 Qiagen
        11.8.1 Qiagen Company Detail
        11.8.2 Qiagen Business Overview
        11.8.3 Qiagen Non-invasive Parenteral Screening Introduction
        11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.8.5 Qiagen Recent Development
    11.9 Agilent Technologies
        11.9.1 Agilent Technologies Company Detail
        11.9.2 Agilent Technologies Business Overview
        11.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
        11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.9.5 Agilent Technologies Recent Development
    11.10 BGI Group
        11.10.1 BGI Group Company Detail
        11.10.2 BGI Group Business Overview
        11.10.3 BGI Group Non-invasive Parenteral Screening Introduction
        11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2017-2022)
        11.10.5 BGI Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Instruments
    Table 3. Key Players of Consumables
    Table 4. Global Non-invasive Parenteral Screening Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Non-invasive Parenteral Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Non-invasive Parenteral Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Non-invasive Parenteral Screening Market Share by Region (2017-2022)
    Table 8. Global Non-invasive Parenteral Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Non-invasive Parenteral Screening Market Share by Region (2023-2028)
    Table 10. Non-invasive Parenteral Screening Market Trends
    Table 11. Non-invasive Parenteral Screening Market Drivers
    Table 12. Non-invasive Parenteral Screening Market Challenges
    Table 13. Non-invasive Parenteral Screening Market Restraints
    Table 14. Global Non-invasive Parenteral Screening Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Non-invasive Parenteral Screening Market Share by Players (2017-2022)
    Table 16. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2021)
    Table 17. Ranking of Global Top Non-invasive Parenteral Screening Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Non-invasive Parenteral Screening Product Solution and Service
    Table 21. Date of Enter into Non-invasive Parenteral Screening Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Non-invasive Parenteral Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2017-2022)
    Table 25. Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2023-2028)
    Table 27. Global Non-invasive Parenteral Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2017-2022)
    Table 29. Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2023-2028)
    Table 31. North America Non-invasive Parenteral Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Non-invasive Parenteral Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Non-invasive Parenteral Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Non-invasive Parenteral Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Non-invasive Parenteral Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Non-invasive Parenteral Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 41. GE Healthcare Company Detail
    Table 42. GE Healthcare Business Overview
    Table 43. GE Healthcare Non-invasive Parenteral Screening Product
    Table 44. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 45. GE Healthcare Recent Development
    Table 46. Philips Company Detail
    Table 47. Philips Business Overview
    Table 48. Philips Non-invasive Parenteral Screening Product
    Table 49. Philips Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 50. Philips Recent Development
    Table 51. Illumina Company Detail
    Table 52. Illumina Business Overview
    Table 53. Illumina Non-invasive Parenteral Screening Product
    Table 54. Illumina Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 55. Illumina Recent Development
    Table 56. Thermo Fisher Scientific Company Detail
    Table 57. Thermo Fisher Scientific Business Overview
    Table 58. Thermo Fisher Scientific Non-invasive Parenteral Screening Product
    Table 59. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 60. Thermo Fisher Scientific Recent Development
    Table 61. Roche Company Detail
    Table 62. Roche Business Overview
    Table 63. Roche Non-invasive Parenteral Screening Product
    Table 64. Roche Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Development
    Table 66. PacBio Company Detail
    Table 67. PacBio Business Overview
    Table 68. PacBio Non-invasive Parenteral Screening Product
    Table 69. PacBio Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 70. PacBio Recent Development
    Table 71. Perkinelmer Company Detail
    Table 72. Perkinelmer Business Overview
    Table 73. Perkinelmer Non-invasive Parenteral Screening Product
    Table 74. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 75. Perkinelmer Recent Development
    Table 76. Qiagen Company Detail
    Table 77. Qiagen Business Overview
    Table 78. Qiagen Non-invasive Parenteral Screening Product
    Table 79. Qiagen Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 80. Qiagen Recent Development
    Table 81. Agilent Technologies Company Detail
    Table 82. Agilent Technologies Business Overview
    Table 83. Agilent Technologies Non-invasive Parenteral Screening Product
    Table 84. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 85. Agilent Technologies Recent Development
    Table 86. BGI Group Company Detail
    Table 87. BGI Group Business Overview
    Table 88. BGI Group Non-invasive Parenteral Screening Product
    Table 89. BGI Group Revenue in Non-invasive Parenteral Screening Business (2017-2022) & (US$ Million)
    Table 90. BGI Group Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-invasive Parenteral Screening Market Share by Type: 2021 VS 2028
    Figure 2. Instruments Features
    Figure 3. Consumables Features
    Figure 4. Global Non-invasive Parenteral Screening Market Share by Application in 2021 & 2028
    Figure 5. Diagnostic Laboratories Case Studies
    Figure 6. Hospitals Case Studies
    Figure 7. Non-invasive Parenteral Screening Report Years Considered
    Figure 8. Global Non-invasive Parenteral Screening Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Non-invasive Parenteral Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Non-invasive Parenteral Screening Market Share by Region: 2021 VS 2028
    Figure 11. Global Non-invasive Parenteral Screening Market Share by Players in 2021
    Figure 12. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Revenue in 2021
    Figure 14. North America Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Non-invasive Parenteral Screening Market Share by Country (2017-2028)
    Figure 16. United States Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Non-invasive Parenteral Screening Market Share by Country (2017-2028)
    Figure 20. Germany Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Non-invasive Parenteral Screening Market Share by Region (2017-2028)
    Figure 28. China Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Non-invasive Parenteral Screening Market Share by Country (2017-2028)
    Figure 36. Mexico Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Non-invasive Parenteral Screening Market Share by Country (2017-2028)
    Figure 40. Turkey Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Non-invasive Parenteral Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 43. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 44. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 47. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 48. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 49. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 50. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 51. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group
Frequently Asked Questions
Non-invasive Parenteral Screening report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-invasive Parenteral Screening report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-invasive Parenteral Screening report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports